Abstract OBJECTIVE: To measure the expression of phosphatidylinositol 3-kinase (PI3K) and protein kinase B (PKB) in liver tissue among low-birth-weight newborn rats treated with L-arginine (L-Arg) in early life, and to investigate the effect of L-Arg on insulin resistance. METHODS: Eighteen pregnant rats were randomly divided into three groups: control, model and intervention (n=6 each). The control group was fed with normal protein feed (protein content=21%) during pregnancy to establish a normal-birth-weight newborn rat model, and the model and intervention groups were fed with low-protein feed (protein content=10%) during pregnancy to establish a low-birth-weight newborn rat model. Newborn rats from the three pregnant rat groups were also assigned to control, model and intervention groups. During 21 days of lactation, maternal rats in the control and model groups were fed with normal protein feed and normal drinking water, while maternal rats in the intervention group were fed with normal protein feed and drinking water rich in L-Arg (200 mg/kg·d). After ablactation, the three groups of newborn rats were fed with normal protein feed and normal drinking water. Liver tissue samples were collected from these newborn rats at 1, 3 and 8 weeks after birth. Protein expression of PI3K and PKB in liver tissue was measured by Western blot. RESULTS: At 1 week after birth, the newborn rats in the intervention group had significantly higher protein expression of PI3K than in the model group (P=0.045), but there was no significant difference when compared with the control group (P=0.503). At 8 weeks after birth, the newborn rats in the intervention group had significantly higher protein expression of PKB than the model group (P=0.039), but there was no significant difference when compared with the control group (P>0.05). CONCLUSIONS: A supplement of L-Arg in early life can boost protein synthesis, increase protein expression of PI3K and PKB in liver tissue, promote insulin signaling and reduce insulin resistance.
LUO Kai-Ju,CHEN Ping-Yang,XIE Zong-De et al. Effects of L-Arg on expression of PI3K and PKB in liver among low-birth-weight newborn rats[J]. CJCP, 2013, 15(8): 682-685.
LUO Kai-Ju,CHEN Ping-Yang,XIE Zong-De et al. Effects of L-Arg on expression of PI3K and PKB in liver among low-birth-weight newborn rats[J]. CJCP, 2013, 15(8): 682-685.
Rinaudo P, Wang E. Fetal programming and metabolic syndrome[J]. Annu Rev Physiol, 2012, 74: 107-130.
[2]
Schultze SM, Jensen J, Hemmings BA, Tschopp O, Niessen M. Promiscuous affairs of PKB/AKT isoforms in metabolism[J]. Arch Physiol Biochem, 2011, 117(2): 70-77.
[6]
Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS, et al. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice[J]. J Biol Chem, 2002, 277(26): 23301-23307.
Xie Z, Dong Q, Ge J, Chen P, Li W, Hu J. Effect of low birth weight on impaired renal development and function and hypertension in rat model[J]. Ren Fail, 2012, 34(6): 754-759.
[8]
Andreelli F, Laville M, Ducluzeau PH, Vega N, Vallier P, Khalfallah Y, et al. Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients[J]. Diabetologia, 1999, 42(3): 358-364.
[4]
Lucas A. Programming by early nutrition: an experimental approach[J]. J Nutr, 1998, 128(2 Suppl): 401S-406S.
Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS, et al. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice[J]. J Biol Chem, 2002, 277(26): 23301-23307.
Andreelli F, Laville M, Ducluzeau PH, Vega N, Vallier P, Khalfallah Y, et al. Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients[J]. Diabetologia, 1999, 42(3): 358-364.
Escudero A, Petzold G, Moreno J, Gonzalez M, Junod J, Aguayo C, et al. Supplementation with apple enriched with L-arginine may improve metabolic control and survival rate in alloxan-induced diabetic rats[J]. Biofactors, 2013[Epub ahead of print].
[13]
Escudero A, Petzold G, Moreno J, Gonzalez M, Junod J, Aguayo C, et al. Supplementation with apple enriched with L-arginine may improve metabolic control and survival rate in alloxan-induced diabetic rats[J]. Biofactors, 2013[Epub ahead of print].
[14]
Marchetti P, Bugliani M, Boggi U, Masini M, Marselli L. The pancreatic beta cells in human type 2 diabetes[J]. Adv Exp Med Biol, 2012, 771: 288-309.
Fu WJ, Haynes TE, Kohli R, Hu J, Shi W, Spencer TE, et al. Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats[J]. J Nutr, 2005, 135(4): 714-721.
[14]
Marchetti P, Bugliani M, Boggi U, Masini M, Marselli L. The pancreatic beta cells in human type 2 diabetes[J]. Adv Exp Med Biol, 2012, 771: 288-309.
Fu WJ, Haynes TE, Kohli R, Hu J, Shi W, Spencer TE, et al. Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats[J]. J Nutr, 2005, 135(4): 714-721.
[17]
Feng Y, Li J, Yang J, Yang Q, Lv Q, Gao Y, et al. Synergistic effects of taurine and L-arginine on attenuating insulin resistance hypertension[J]. Adv Exp Med Biol, 2013, 775: 427-435.
[17]
Feng Y, Li J, Yang J, Yang Q, Lv Q, Gao Y, et al. Synergistic effects of taurine and L-arginine on attenuating insulin resistance hypertension[J]. Adv Exp Med Biol, 2013, 775: 427-435.
